Active ingredients
Pharmacological Group
Analogs
Complete analogs for the substance
- 1-9.9€ ≈100% Arbidol
- 1.1-9.1€ ≈100% Umifenovir
- 1.5-2.5€ ≈100% Афлюдол
- 1.8-4€ ≈100% Арпефлю
- 3.7-5.1€ ≈100% Arbidol Maximum
- 87% — Methylphenylthiomethyl-dimethylaminomethyl-hydroxy-bromindol carbonic acid ethyl ester [Methylphenylthiomethyl-dimethylaminomethyl-hydroxy-bromindol carboxylic acid ethyl ester and more 1Umifenovir]
- 75% — Arpetolid [Methylphenylthiomethyl-dimethylaminomethyl-hydroxy-bromindol carboxylic acid ethyl ester]
- 68% — Ethylic ether 6-bromine-5-hydroxy-1-methyl-4-dimethylaminominomethyl- 2-phenylthiomthylindole-3-carboxylic acid hydrochloride monohydrate [Methylphenylthiomethyl-dimethylaminomethyl-hydroxy-bromindol carboxylic acid ethyl ester and more 1Diethyl ether]
- 56% — Immunex [Echinaceae purpurae herbae extract]
- Show all
Analogs by action
Used in the treatment of
- J42 Unspecified chronic bronchitis
- J40 Bronchitis, not specified as acute or chronic
- J18.9 Pneumonia, unspecified
- J10 Influenza due to other identified influenza virus
- B00.9 Herpesviral infection, unspecified
- B00.0 Eczema herpeticum
- A08.0 Rotaviral enteritis
- T81.4 Infection following a procedure, not elsewhere classified
- J10.0 Influenza with pneumonia, other influenza virus identified
- J80 Adult respiratory distress syndrome
- D84.8 Other specified immunodeficiencies
- B34.8 Other viral infections of unspecified site
- Z25.1 Need for immunization against influenza
Contraindications of the components
Противопоказания Umifenovir.
Повышенная чувствительность к умифеновиру; детский возраст до 2-12 лет в зависимости от показания и лекарственной формы.Использование препарата Umifenovir при кормлении грудью.
Применение умифеновира при беременности противопоказано.Неизвестно, проникает ли умифеновир или его метаболиты в грудное молоко у женщин в период лактации. При необходимости применения умифеновира в этот период грудное вскармливание следует прекратить.